BTK expression is upregulated postmortem in the brains of AD patients and 5xFAD mice (mouse model of AD) (Keaney et al., 2019), and inhibition of BTK suppresses microglial activation and synaptic loss by deactivating PLCγ2 (Keaney et al., 2019). This evidence concerns the gene BTK and Alzheimer disease.